Under the deal, Verily will test wastewater samples from up to 400 sites nationwide for the presence of COVID-19 and mpox. The findings will help health departments better understand disease trends and respond promptly to any outbreaks.
Verily and CDC did not disclose the price of the contract, though STAT reports it’s $38M.
The CDC launched its National Wastewater Surveillance System in 2020 to better track the presence of SARS-CoV-2 collected from wastewater samples nationwide.
Learn more here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
